Regal Assets Analytics

SanaCurrents

SanaCurrents Following Stock Highs After Coronavirus Developments

By |2020-05-05T08:58:49-04:00May 4th, 2020|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: |

Last Friday, the FDA granted emergency use authorization (EUA) to [...]

2019 Winding Down. A Retrospective from SanaCurrents

By |2020-10-20T14:53:02-04:00December 6th, 2019|Categories: Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

As 2019 winds to a close, SanaCurrents can look back [...]

New Approaches to Alzheimer’s After a String of Failures

By |2020-10-20T14:52:53-04:00April 26th, 2019|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Did you ever wonder how a company like Biogen, valued [...]

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

By |2019-03-25T11:45:49-04:00March 25th, 2019|Categories: Bill Langbein, Case Study, Education, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: , , , , |

One of the strongest performing biopharmaceutical stocks this year is [...]

SanaCurrents Increasing Monthly Sentiment Report Frequency

By |2020-01-25T16:45:27-05:00February 5th, 2019|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: |

SanaCurrents is increasing the frequency of its sentiment reports to subscribers [...]